Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 10 03:31PM ET
11.85
Dollar change
+0.34
Percentage change
3.00
%
Index- P/E2.13 EPS (ttm)5.57 Insider Own49.13% Shs Outstand806.68M Perf Week5.75%
Market Cap8.77B Forward P/E- EPS next Y-1.11 Insider Trans-2.18% Shs Float376.18M Perf Month-4.24%
Income4.74B PEG- EPS next Q-0.23 Inst Own61.93% Short Float13.62% Perf Quarter4.45%
Sales158.30M P/S55.38 EPS this Y-114.22% Inst Trans4.95% Short Ratio8.30 Perf Half Y6.13%
Book/sh7.35 P/B1.61 EPS next Y-48.88% ROA109.72% Short Interest51.22M Perf Year10.79%
Cash/sh7.69 P/C1.54 EPS next 5Y- ROE149.26% 52W Range8.24 - 13.06 Perf YTD5.57%
Dividend Est.- P/FCF- EPS past 5Y0.08% ROI81.76% 52W High-9.19% Beta1.25
Dividend TTM- Quick Ratio27.75 Sales past 5Y493.24% Gross Margin82.02% 52W Low43.78% ATR (14)0.32
Dividend Ex-Date- Current Ratio27.91 EPS Y/Y TTM541.27% Oper. Margin-661.14% RSI (14)56.16 Volatility2.14% 2.58%
Employees908 Debt/Eq0.07 Sales Y/Y TTM101.44% Profit Margin2991.76% Recom1.18 Target Price16.94
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q131.72% Payout0.00% Rel Volume0.56 Prev Close11.51
Sales Surprise79.47% EPS Surprise149.32% Sales Q/Q154.96% EarningsAug 08 BMO Avg Volume6.17M Price11.85
SMA201.77% SMA502.42% SMA2007.11% Trades Volume3,222,621 Change3.00%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Outperform $17
Jan-05-24Initiated Piper Sandler Overweight $20
Dec-12-23Initiated Deutsche Bank Buy $14
Oct-17-23Initiated Guggenheim Buy $17
Jun-08-23Initiated BofA Securities Neutral $10.50
Oct-27-22Initiated JP Morgan Overweight $7
May-23-22Initiated SVB Leerink Outperform $6
Apr-29-22Initiated Cantor Fitzgerald Overweight $15
Dec-15-21Initiated Goldman Buy $15
Nov-08-21Initiated H.C. Wainwright Buy $14
Sep-18-24 07:30AM
Sep-10-24 06:30AM
06:30AM
Sep-09-24 07:00AM
Sep-04-24 06:55PM
07:00AM Loading…
Aug-08-24 07:00AM
Jul-25-24 04:05PM
May-31-24 08:04AM
May-30-24 11:53AM
08:20AM
07:00AM
May-27-24 06:28PM
06:13PM
May-16-24 04:05PM
May-08-24 02:43AM
02:04PM Loading…
May-07-24 02:04PM
May-01-24 10:47AM
Apr-25-24 08:00AM
Apr-12-24 11:09AM
Apr-02-24 07:00AM
Mar-27-24 01:55PM
Mar-26-24 06:22PM
Mar-17-24 08:50AM
Mar-14-24 07:04AM
Feb-15-24 02:45AM
Feb-13-24 07:00AM
Feb-10-24 02:55AM
Jan-30-24 04:05PM
Dec-27-23 08:05PM
Dec-20-23 04:30PM
09:00AM Loading…
Dec-14-23 09:00AM
Nov-28-23 07:00AM
02:38AM
Nov-27-23 08:00AM
Nov-14-23 01:00PM
Nov-13-23 07:00AM
Nov-10-23 08:00AM
Oct-30-23 05:30PM
Oct-24-23 08:00AM
Oct-23-23 03:02PM
10:31AM
09:52AM
06:55AM
03:49AM
01:00AM
Oct-13-23 08:00AM
Oct-05-23 05:01AM
Oct-03-23 07:00AM
Sep-30-23 05:00AM
Sep-26-23 06:00AM
Sep-11-23 08:00AM
Sep-09-23 10:51AM
Aug-17-23 04:05PM
Aug-14-23 07:00AM
Aug-03-23 04:05PM
Aug-02-23 04:05PM
Jul-27-23 08:00AM
Jul-26-23 10:21AM
Jul-13-23 05:50PM
Jul-11-23 08:00AM
Jun-28-23 08:57AM
07:00AM
Jun-26-23 04:05PM
Jun-22-23 07:30AM
Jun-21-23 05:00PM
May-16-23 07:00AM
Apr-04-23 07:37AM
07:37AM
Mar-28-23 08:00AM
Mar-15-23 07:45AM
Mar-14-23 04:07PM
08:00AM
Mar-07-23 08:00AM
Feb-21-23 08:32PM
Feb-13-23 04:17PM
07:00AM
Feb-02-23 09:14PM
Feb-01-23 04:05PM
Jan-30-23 08:00AM
Jan-04-23 06:05AM
Dec-07-22 06:30AM
Dec-01-22 08:00AM
Nov-14-22 07:00AM
Nov-10-22 09:00AM
Nov-08-22 06:15AM
Nov-07-22 04:01PM
Oct-18-22 04:00PM
Aug-30-22 07:00AM
Aug-16-22 11:44AM
Aug-15-22 07:00AM
Aug-14-22 10:53AM
Aug-03-22 07:00AM
Jul-23-22 09:00AM
Jun-30-22 09:18AM
Jun-28-22 06:27AM
06:10AM
06:00AM
Jun-15-22 04:30PM
May-24-22 06:00AM
May-19-22 04:30PM
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
QVT Financial LPDirector by DeputizationSep 26 '24Sale11.82876,00010,354,32022,179,358Sep 26 09:22 PM
QVT Financial LPDirector by DeputizationSep 25 '24Sale11.7750,000588,50023,055,358Sep 26 09:22 PM
MANCHESTER KEITH SDirectorSep 24 '24Sale11.62368,0524,278,6041,412,126Sep 26 08:35 PM
MANCHESTER KEITH SDirectorSep 25 '24Sale11.77134,9481,587,7041,277,178Sep 26 08:35 PM
Gold Daniel AllenDirectorSep 24 '24Sale11.621,565,67018,200,9145,723,423Sep 26 08:34 PM
Gold Daniel AllenDirectorSep 25 '24Sale11.77991,59311,666,3894,731,830Sep 26 08:34 PM
Gold Daniel AllenDirectorSep 26 '24Sale11.82876,00010,354,32022,179,358Sep 26 08:34 PM
Gold Daniel AllenDirectorSep 24 '24Sale11.62577,1866,709,7872,079,059Sep 26 08:34 PM
Gold Daniel AllenDirectorSep 25 '24Sale11.77415,5514,889,3171,713,508Sep 26 08:34 PM
BNEI ZAHAV LLCDirectorSep 25 '24Proposed Sale11.7623,917281,264Sep 25 04:30 PM
RIOJA DOLCE LLCDirectorSep 25 '24Proposed Sale11.76170,8172,008,808Sep 25 04:25 PM
KEITH S MANCHESTER REVOCABLE TDirectorSep 25 '24Proposed Sale11.76134,9481,586,988Sep 25 04:23 PM
RIOJA LIETO LLCDirectorSep 25 '24Proposed Sale11.76170,8172,008,808Sep 25 04:20 PM
DANIEL GOLD & LAURA GOLDDirectorSep 25 '24Proposed Sale11.76991,59311,661,134Sep 25 04:19 PM
Gline MatthewCEOSep 23 '24Option Exercise3.851,550,0005,967,50019,853,800Sep 24 09:01 PM
Gline MatthewCEOSep 23 '24Sale11.791,983,25723,382,60017,870,543Sep 24 09:01 PM
Kumar RakhiChief Accounting OfficerSep 23 '24Option Exercise3.85250,000962,500459,322Sep 24 09:01 PM
Kumar RakhiChief Accounting OfficerSep 23 '24Sale11.89250,0002,972,500209,322Sep 24 09:01 PM
DANIEL GOLD &LAURA GOLD JT TENDirectorSep 24 '24Proposed Sale11.621,565,67018,200,914Sep 24 07:53 PM
RIOJA LIETO LLCDirectorSep 24 '24Proposed Sale11.63269,7123,135,402Sep 24 07:52 PM
RIOJA DOLCE LLCDirectorSep 24 '24Proposed Sale11.63269,7123,135,402Sep 24 07:51 PM
BNEI ZAHAV LLCDirectorSep 24 '24Proposed Sale11.6237,762438,983Sep 24 07:48 PM
KEITH S MANCHESTER REVOCABLE TDirectorSep 24 '24Proposed Sale11.63368,0524,281,550Sep 24 07:43 PM
Gline MatthewOfficerSep 23 '24Proposed Sale11.791,983,25723,383,088Sep 23 04:53 PM
Kumar RakhiOfficerSep 23 '24Proposed Sale11.89250,0002,972,360Sep 23 04:47 PM
Venker EricPresident & COOFeb 09 '24Option Exercise3.8596,950373,258629,157Feb 09 09:00 PM
Venker EricPresident & COOFeb 09 '24Sale10.9296,9501,058,694532,207Feb 09 09:00 PM
Ramaswamy Vivek10% OwnerJan 02 '24Sale11.053,000,00033,150,00051,929,426Jan 03 04:56 PM